Biologics Outsourcing Market

Request Sample Copy @ https://www.themarketinsights.com/request-sample/265110

Market Segmentation

The global biologics outsourcing market has been analyzed on the basis of product type, source, application, end-use, and region. Based on the product type, the market is segmented into antibodies, recombinant proteins, vaccines, and others. Among these, antibodies segment is estimated to hold a prominent share in the market. Based on source, the market is segmented into human, microbial, and others. The microbial segment is projected to exhibit a considerable growth during the forecast period.Based on application, the market is segmented into stem cell research, vaccine and therapeutics development, blood & blood-related products development, cellular and gene therapy products development, and others. Stem cell research segment is estimated to hold a prominent share in the market. Based on end-user, the market covers the analysis of therapeutics & diagnostics, and research. Geographically, the market is analyzed into North America, Western Europe, Eastern Europe, Asia Pacific, Latin America, and Middle East & Africa.

Check for Discount @ https://www.themarketinsights.com/check-discount/265110

Market Structure and Competition Landscape

The global biologics outsourcing market is characterized by the presence of significant number of players. Some of the prominent players operating in the market include Lonza Group AG, Wuxi Biologics (Cayman) Inc., Boehringer Ingelheim International GmbH, Samsung Biologics Co. Ltd., Thermo Fisher Scientific Inc., Wuxi Biologics (Cayman) Inc., Genescript Biotech Corp., and others. Growing focus on biologics and increasing R&D spending on biologics drugs by these industry players are expected to drive the market. Some of the key developments in the global biologics outsourcing market include:In January 2022, Samsung Biologics agreed to pay US$ 2.3 billion for Biogen s 50% stake in Samsung Bioepis, a joint venture between the two companies. This is aimed to improve Samsung Bioepis biosimilar development capabilities and future performance in new drug development.In March 2021, WuXi acquired a single-use biologics production plant in Hangzhou, China, from Pfizer Inc.

Report Customization available as per requirements @ https://www.themarketinsights.com/request-customization/265110

Table of Content

Chapter One: Market Introduction1.1. Scope of Study1.2. Problem Statement1.3. Market SegmentationChapter Two: Assumptions and AcronymsChapter Three: Executive Summary3.1. Global Market in20223.2. Analyst Insights & Recommendations3.3. Growth Opportunities and Key Strategies3.4. Supply-side and Demand-side TrendsChapter Four: Research MethodologyChapter Five: Analysis of COVID-19 Impact and Road AheadChapter Six: Market Indicators and Background6.1. Macro-Economic Factors6.2. Forecasting FactorsRobust assessment of various factors including industrial performance, industry players expenditures, and economic conditions among others6.3. Supply Chain & Value Chain Analysis6.4. Industry SWOT Analysis6.5. PESTLE Analysis6.6. Porter s Five Forces AnalysisChapter Seven: Rules & RegulationsChapter Eight: Global and Regional Market Dynamics8.1. Drivers8.2. Restraints8.3. Trends8.4. OpportunitiesChapter Nine: Global Biologics Outsourcing Market: Key Investment Analysis9.1. By Leading Biologics Companies9.2. Technological Assessment9.3. By Region9.4. M&A ActivitiesRobust assessment of major investments made by various industry players along with key technological assessment, and key end-use sectorChapter Ten: Global Biologics Outsourcing Market: Service Cost Analysis10.1. By Service Type10.1.1. Antibody Production Service10.1.2. Custom Monoclonal Antibody Production Service10.1.3. Custom Polyclonal Antibody Production Service10.1.4. Protein Production Service10.1.5. Gene Editing ServiceChapter Eleven: Global Biologics Outsourcing Market: Biological Development Phase Analysis11.1. Discovery11.2. Pre-Clinical11.3. Clinical11.4. CommercializationChapter Twelve: Parent Market Overview12.1. Global Life Sciences Market12.2. Global Healthcare MarketChapter Thirteen: Segmental Analysis13.1. Global Biologics Outsourcing Market by Product Type13.1.1. Segment Overview13.1.1.1. Antibodies13.1.1.1.1. Monoclonal Antibody13.1.1.1.2. Antibody Drug Conjugates13.1.1.1.3. Others (Polyclonal Antibodies etc. )13.1.1.2. Recombinant proteins13.1.1.3. Vaccines13.1.1.4. Others (Fusion Proteins, etc. )13.2. Global Biologics Outsourcing Market by Source13.2.1. Segment Overview13.2.1.1. Human13.2.1.2. Microbial13.2.1.3. Others (Transgenic Animals such as Avian, Insects, etc. )13.3. Global Biologics Outsourcing Market by Application13.3.1. Segment Overview13.3.1.1. Stem Cell Research13.3.1.2. Vaccine and Therapeutics Development13.3.1.3. Blood & Blood-Related Products Development13.3.1.4. Cellular and Gene Therapy Products Development13.3.1.5. Others (Tissue & Tissue Related Products Development)13.4. Global Biologics Outsourcing Market by End Use13.4.1. Segment Overview13.4.1.1. Therapeutics and Diagnostics13.4.1.2. Research13.5. Global Biologics Outsourcing Market by Region13.5.1. North America13.5.2. Latin America13.5.3. Western Europe13.5.4. Eastern Europe13.5.5. Asia Pacific13.5.6. Middle East & AfricaChapter Fourteen: Regional Analysis14.1. North America Biologics Outsourcing Market Analysis and Forecast2019-202814.1.1. Market Overview14.1.2. North America Biologics Outsourcing Market by Product Type14.1.3. North America Biologics Outsourcing Market by Source14.1.4. North America Biologics Outsourcing Market by Application14.1.5. North America Biologics Outsourcing Market by End Use14.1.6. North America Biologics Outsourcing Market by Country14.1.6.1. US14.1.6.2. Canada14.2. Latin America Biologics Outsourcing Market Analysis and Forecast2019-202814.2.1. Market Overview14.2.2. Latin America Biologics Outsourcing Market by Product Type14.2.3. Latin America Biologics Outsourcing Market by Source14.2.4. Latin America Biologics Outsourcing Market by Application14.2.5. Latin America Biologics Outsourcing Market by End Use14.2.6. Latin America Biologics Outsourcing Market by Country14.2.6.1. Brazil14.2.6.2. Mexico14.2.6.3. Rest of Latin America14.3. Western Europe Biologics Outsourcing Market Analysis and Forecast2019-202814.3.1. Market Overview14.3.2. Western Europe Biologics Outsourcing Market by Product Type14.3.3. Western Europe Biologics Outsourcing Market by Source14.3.4. Western Europe Biologics Outsourcing Market by Application14.3.5. Western Europe Biologics Outsourcing Market by End Use14.3.6. Western Europe Biologics Outsourcing Market by Country14.3.6.1. Germany14.3.6.2. UK14.3.6.3. France14.3.6.4. Spain14.3.6.5. Italy14.3.6.6. Benelux14.3.6.7. Nordic14.3.6.8. Rest of Western Europe14.4. Eastern Europe Biologics Outsourcing Market Analysis and Forecast2019-202814.4.1. Market Overview14.4.2. Eastern Europe Biologics Outsourcing Market by Product Type14.4.3. Eastern Europe Biologics Outsourcing Market by Source14.4.4. Eastern Europe Biologics Outsourcing Market by Application14.4.5. Eastern Europe Biologics Outsourcing Market by End Use14.4.6. Eastern Europe Biologics Outsourcing Market by Country14.4.6.1. Russia14.4.6.2. Poland14.4.6.3. Rest of Eastern Europe14.5. Asia Pacific Biologics Outsourcing Market Analysis and Forecast2019-202814.5.1. Market Overview14.5.2. Asia Pacific Biologics Outsourcing Market by Product Type14.5.3. Asia Pacific Biologics Outsourcing Market by Source14.5.4. Asia Pacific Biologics Outsourcing Market by Application14.5.5. Asia Pacific Biologics Outsourcing Market by End Use14.5.6. Asia Pacific Biologics Outsourcing Market by Country14.5.6.1. China14.5.6.2. Japan14.5.6.3. India14.5.6.4. South Korea14.5.6.5. Australia14.5.6.6. ASEAN14.5.6.7. Rest of Asia-Pacific14.6. Middle East & Africa Biologics Outsourcing Market Analysis and Forecast2019-202814.6.1. Market Overview14.6.2. Middle East & Africa Biologics Outsourcing Market by Product Type14.6.3. Middle East & Africa Biologics Outsourcing Market by Source14.6.4. Middle East & Africa Biologics Outsourcing Market by Application14.6.5. Middle East & Africa Biologics Outsourcing Market by End Use14.6.6. Middle East & Africa Biologics Outsourcing Market by Country14.6.6.1. GCC14.6.6.2. South Africa14.6.6.3. Turkey14.6.6.4. Rest of the Middle East & AfricaChapter Fifteen: Competitive Landscape15.1. Competition Dashboard15.1.1. Global and Regional Market Share Analysis15.1.2. Market Structure15.2. Competitive Benchmarking15.3. Key Strategy Analysis15.4. Company Profiles15.4.1. Lonza Group AG15.4.1.1. Company Overview15.4.1.2. Product/Service Offerings15.4.1.3. Key Financials15.4.1.4. Recent Developments15.4.2. Wuxi Biologics (Cayman) Inc.15.4.2.1. Company Overview15.4.2.2. Product/Service Offerings15.4.2.3. Financials15.4.2.4. Recent Developments15.4.3. Boehringer Ingelheim International GmbH15.4.3.1. Company Overview15.4.3.2. Product/Service Offerings15.4.3.3. Financials15.4.3.4. Recent Developments15.4.4. Abzena Ltd.15.4.4.1. Company Overview15.4.4.2. Product/Service Offerings15.4.4.3. Financials15.4.4.4. Recent Developments15.4.5. GL Biochem Corp.15.4.5.1. Company Overview15.4.5.2. Product/Service Offerings15.4.5.3. Financials15.4.5.4. Recent Developments15.4.6. Catalent, Inc.15.4.6.1. Company Overview15.4.6.2. Product/Service Offerings15.4.6.3. Financials15.4.6.4. Recent Developments15.4.7. Samsung Biologics Co. Ltd.15.4.7.1. Company Overview15.4.7.2. Product/Service Offerings15.4.7.3. Financials15.4.7.4. Recent Developments15.4.8. ThermoFisher Scientific Inc.15.4.8.1. Company Overview15.4.8.2. Product/Service Offerings15.4.8.3. Financials15.4.8.4. Recent Developments15.4.9. Syngene International Ltd.15.4.9.1. Company Overview15.4.9.2. Product/Service Offerings15.4.9.3. Financials15.4.9.4. Recent Developments15.4.10. Rentschler Biopharma SE15.4.10.1. Company Overview15.4.10.2. Product/Service Offerings15.4.10.3. Financials15.4.10.4. Recent Developments15.4.11. Abbvie Inc.15.4.11.1. Company Overview15.4.11.2. Product/Service Offerings15.4.11.3. Financials15.4.11.4. Recent Developments15.4.12. Genscript Biotech Corp.15.4.12.1. Company Overview15.4.12.2. Product/Service Offerings15.4.12.3. Financials15.4.12.4. Recent Developments*List of companies is not exhaustiveChapter Sixteen: Disclaimer

Direct ContactJessica Joyal+1(213)338-8279 | +1(877)376-9989sales@themarketinsights.com

About us.Delivering foresights along with statistical analysis of the operational business industry impacts has been our foremost priority. With the constant developments in the research & development industry, we have always challenged the conventional research methodologies and discovered new research tactics to evolve the growing B2B requirements.

This release was published on openPR.

Read the original post:
Biologics Outsourcing Market : Latest Research Reveals Key Trends for Business Growth| Lonza Group AG, Wuxi Bi - openPR